What are the infectious risks with disease-modifying drugs for multiple sclerosis and how to reduce them? A review of literature
| Autor: | Pourcher, V. |
|---|---|
| Zdroj: | In Revue Neurologique May 2020 176(4):235-243 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
| Autor: | Pourcher, V. |
|---|---|
| Zdroj: | In Revue Neurologique May 2020 176(4):235-243 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect